openPR Logo
Press release

Allogenic Cell Therapies Market Size, Share and Scope Analysis to 2030

02-17-2023 04:13 PM CET | IT, New Media & Software

Press release from: Insightace Analytics

/ PR Agency: Insightace Analytics
Allogenic Cell Therapies Market Size, Share and Scope Analysis

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Allogenic Cell Therapies Market- by Cell Type(Cardiosphere-Derived Cells (CDCs), Fibroblasts, T-cells, Mesenchymal Stem Cells (MSCs), Hematopoietic Stem Cells (HSCs) and Others),Tissue Source(Skin, Blood, PBC, BM and Others), Indication (Acute graft-versus-host disease (GVHD), Chronic Ulcers and Diabetic Foot Ulcers, Osteoarthritis, Crohn's Disease, Cardiovascular Disease, Solid Tumors/Cancers and Others (Alzheimer's Disease, etc.)), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."

Get Free Sample Copy of Report : https://www.insightaceanalytic.com/request-sample/1084

According to the latest research by InsightAce Analytic, the globalAllogenic Cell Therapiesmarketwill be valued at US$ 988.37 Million in 2021. It is expected to reach US$ 2424.72 Million by 2030, with a CAGR of 10.7% during a forecast period of 2022-2030.

Products used in allogeneic cell treatment are showing promising pre- and post-clinical outcomes. Healthy cells from unrelated donors are used to construct allogeneic cell treatments, which rely on a single source of cells to treat many patients. The patient obtains healthy cells (stem cells) from a donor to replace their own damaged or destroyed cells throughout the treatment. As a result of the rising demand for new and improved therapies for immunological, neurodegenerative, and myocardial infarctions, allogeneic cell therapy sales, stem cell therapy activity, research activity, and financing for cell-based research have all increased.

Several factors, such as the rising prevalence of chronic illnesses like cancer, diabetes, and cardiovascular diseases, rising government funding for stem cell therapies, an ageing population, developing healthcare infrastructure, technological advancements, expanding public awareness about the benefits of allogeneic cell therapies, and more are anticipated to drive the demand for the allogeneic cell therapy manufacturing market during the forecast period. Allogeneic cell therapies are being introduced by numerous pharmaceutical companies to treat patients with chronic illnesses.

In response to the growing need for low-cost and efficient cell and gene therapies, outsourcing contract research organisations (CROs) have boosted bioassay services, enhancing market growth prospects in the near future. Allogeneic cell therapy manufacturing, however, may experience growth restrictions in the upcoming years as a result of high development costs and issues with immunological rejection. North America is anticipated to contribute to the Allogenic Cell Therapies market due to the high prevalence of chronic diseases, increased R&D investments in cell therapy research, and the rapid uptake of cutting-edge technology. In addition, the Asia PacificAllogenic Cell Therapies market is expected to register significant growth. The growing pharmaceutical manufacturing industry in the region, together with rising investments in cell therapy, has played a vital role in the market's growth in the APAC region.

Major market players operating in the Allogenic Cell Therapies market include
AtaraBiotherapeutics, ArtivaBiotherapeutic, Adaptimmune Therapeutics plc, Adicet Bio, Inc., Allogene Therapeutics, Athersys, Inc., BioCardia Inc., Bluebird Bio, BlueRock Therapeutics LP, Bone Therapeutics, Celyad, Capricor Therapeutics, Cellectis, Cyto Therapeutics Pty Limited, Cynata Therapeutics, Century Therapeutics, GammaDelta Therapeutics Limited, Fate Therapeutics, Osiris Therapeutics, Inc., Organogenesis Inc., Mesoblast Ltd, MEDIPOST, Nkarta, Inc., NantKwest, Pluristem Therapeutics Inc, Regeneus, Lineage Cell Therapeutics, Inc., Stempeutics, Stemedica Cell Technologies, Inc., TiGenix (Takeda) and TCR² Therapeutics.

Recent collaborations and agreements in the market:
In January 2022,Rexlemestrocel-L (MPC-06-ID), an allogeneic cell therapy, was tested in a Phase 3 trial on patients with CLBP (chronic low back pain) associated with DDD. Mesoblast Limited (Australi), a global leader in allogeneic cellular medicines for inflammatory diseases, presented the 36-month follow-up results (degenerative disc disease). In this study, a single intra-discal injection of the rexlemestrocel-L+hyaluronic acid (HA) carrier resulted in a significant three-year reduction in back pain.
In November 2021, a non-binding term sheet for the global rights to ALLOB, the allogeneic bone cell therapy of BONE THERAPEUTICS (Belgium), was signed between Link Health Pharma Co., Ltd. and the cell therapy firm.

Curious about this latest version of the report?Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1084

Market Segments
Global Allogenic Cell Therapies Market, by Cell Type, 2022-2030 (Value US$ Mn)
Cardiosphere-Derived Cells (CDCs)
Fibroblasts
T-cells
Mesenchymal Stem Cells (MSCs)
Hematopoietic Stem Cells (HSCs)
Others

Global Allogenic Cell Therapies Market, by Tissue Source, 2022-2030 (Value US$ Mn)
Skin
Blood
PBC
BM
Others

Global Allogenic Cell Therapies Market, by Indication, 2022-2030 (Value US$ Mn)
Acute graft-versus-host disease (GVHD)
Chronic Ulcers and Diabetic Foot Ulcers
Osteoarthritis
Crohn's Disease
Cardiovascular Disease
Solid Tumors/Cancers
Others (Alzheimer's Disease, etc.)

Global Allogenic Cell Therapies Market, by Region, 2022-2030 (Value US$ Mn)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

North America Allogenic Cell Therapies Market, by Country, 2022-2030 (Value US$ Mn)
U.S.
Canada

Europe Allogenic Cell Therapies Market, by Country, 2022-2030 (Value US$ Mn)
Germany
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific Allogenic Cell Therapies Market, by Country, 2022-2030 (Value US$ Mn)
India
China
Japan
South Korea
Australia & New Zealand

Latin America Allogenic Cell Therapies Market, by Country, 2022-2030 (Value US$ Mn)
Brazil
Mexico
Rest of Latin America

Middle East & Africa Allogenic Cell Therapies Market, by Country, 2022-2030 (Value US$ Mn)
GCC Countries
South Africa
Rest of Middle East & Africa

Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Allogenic Cell Therapies market
To receive an industry overview and future trends of theAllogenic Cell Therapies market
To analyzethe Allogenic Cell Therapies market drivers and challenges
To get information on the Allogenic Cell Therapies marketvalue (US$ Mn) forecast to 2030
Significantinvestments, mergers &acquisitions in the Allogenic Cell Therapies marketindustry

For More Information @ https://www.insightaceanalytic.com/customisation/1084

Corporate Office :
Office No.3050, 3rd Floor Marvel Fuego, Magarpatta Rd, Hadapsar, Pune, Maharashtra 411028

Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com

info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Allogenic Cell Therapies Market Size, Share and Scope Analysis to 2030 here

News-ID: 2936737 • Views:

More Releases from Insightace Analytics

Plastic Recycling Market Deep Research Report with Forecast to 2031
Plastic Recycling Market Deep Research Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Plastic Recycling Market Size, Share & Trends Analysis Report By Material (PET, PP, HDPE, LDPE, PS, PVC), Application (Packaging, Automotive, Construction, Textiles) - Market Outlook And Industry Analysis 2031" The Global Plastic Recycling Market Size is valued at 42.06 billion in 2022 and is predicted to reach 77.19 billion by the year 2031 at a 7.17%
Viral and Non-Viral Vector Manufacturing Market Size, Share and Scope Analysis to 2030
Viral and Non-Viral Vector Manufacturing Market Size, Share and Scope Analysis t …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Viral and Non-Viral Vector Manufacturing Market (Vector Type (Viral Vector (Adenoviral Vector, Retroviral Vector, Adeno-Associated Viral Vector, Lentiviral Vector, Vaccinia Viral Vector, Other Viral Vector), Non-Viral Vectors, (Plasmid DNA, Lipid-Based Non-Viral Vector, Polymer-Based Non-Viral Vector, Other Non-Viral Vector (Peptide-Based And Hybrid/Combination))), Diseases (Cancer, Genetic Disorder, And Infectious Diseases), Application (Gene Therapy (Viral Vector, Non-Viral
The Lipid Nanoparticles (LNPs) CDMO Market Size, Share and Trends Analysis to 2030
The Lipid Nanoparticles (LNPs) CDMO Market Size, Share and Trends Analysis to 20 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Lipid Nanoparticles (LNPs) CDMO Market Focus on Nucleic Acids LNPs Segmented By Product (mRNA , Plasmid DNA (pDNA), siRNA, saRNA, microRNA, and Others), Scale Of Operation (Preclinical, Clinical , and Commercial), End-Users (Pharmaceutical Companies, Academic Research Institute, and Diagnostic Laboratories)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030." According to the latest research by
Green Hydrogen Market Size, Share and Trends Analysis Report 2023-2030
Green Hydrogen Market Size, Share and Trends Analysis Report 2023-2030
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Green Hydrogen Market Size, Share & Trends Analysis Report by Application (Oil and Gas, Industrial Feedstock, Mobility, Power Generation) And Technology (Proton Exchange Membrane Electrolyzer, Alkaline Electrolyzer, Anion Exchange Membrane, And Solid Oxide Electrolyzer)- Market Outlook and Industry Analysis 2031" According to company's newest research, the global green hydrogen market size was valued at US$

All 5 Releases


More Releases for Cell

Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic "Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445 Current
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939 This latest report researches the industry structure, sales, revenue,
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY